# Imcyse funding: rounds and investors

> Imcyse has raised $65M across 2 rounds since 2019. Investors include LSP, Epimède and Société Fédérale de Participations et d’Investissement.

Source: https://millionrounds.com/company/imcyse (Millionrounds; every figure on the page links to its filing or article)

Belgium · [Series B startup](https://millionrounds.com/companies)

# Who invested in *Imcyse*

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech Healthcare

Funding summary Updated 26 Oct 2026

**$65M** raised across 2 rounds since 2019, from 2 sources

**$39M** Series B **$26M** Series B

- **Latest round:** Series B, $26M Feb 2021
- **Biggest round:** $39M Series B · Jun 2019
- **Investors:** 4

See who backed them

## The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020 2021

**$39M** Series B

**$26M** Series B

- **First round:** Series B, $39M
- **Biggest round:** $39M
- **Between rounds:** 20 months

## The rounds

- **Feb 2021** Series B **$26M** No investor was named in the report. Source recorded
- **Jun 2019** Series B **$39M** *4 new* [LSP](https://millionrounds.com/fund/lsp) [Epimède](https://millionrounds.com/fund/epimede) Société Fédérale de Participations et d’Investissement Société Régionale d’Investissement de Wallonie Reported by FinSMEs

## Founders and team

From Imcyse's own website: 11 on the team.

- **Denis Bedoret** Chief Executive Officer
- **Andrew Mackie** Chief Business Officer
- **Gene Mack** Chief Financial Officer
- **Jean Van Rampelbergh** Ph.D, Chief Clinical Development Officer
- **Geoffrey Gloire** Ph.D, IP Director
- **Luc Vander Elst** TecOps Director
- **Stefan Yee** Director – representing AS partners - Biogenosis
- **Stijn Van Rompay** Director – representing SVR Invest – Biogenosis
- **Thomas Taapken** Ph.D., Chairman of the Board
- **Vincent Carlier** Ph.D, R&D Director Immunology
- **Vincent G. Brichard** Ph.D., Director – representing LSP 6 Holding

## Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

**Series B** 2019 **Series B** 2021 [LSP](https://millionrounds.com/fund/lsp) [Epimède](https://millionrounds.com/fund/epimede) Société Fédérale de Participations et d’Investissement Société Régionale d’Investissement de Wallonie

## Everyone who backed them

[LSP](https://millionrounds.com/fund/lsp) Growth equity **1** round

[Epimède](https://millionrounds.com/fund/epimede) Growth equity **1** round

Société Fédérale de Participations et d’Investissement no record of our own yet **1** round

Société Régionale d’Investissement de Wallonie no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=imcyse).

## Quick answers about Imcyse

### Who invested in Imcyse?

Imcyse's investors include LSP, Epimède, Société Fédérale de Participations et d’Investissement and Société Régionale d’Investissement de Wallonie.

### How much has Imcyse raised?

Imcyse has raised $65M across 2 rounds since 2019.

### When did Imcyse last raise?

Imcyse's most recent round was a Series B of $26M in Feb 2021.

### What was Imcyse's biggest round?

Imcyse's largest round on record is $39M (Series B), in Jun 2019.

### Who backed Imcyse first?

Imcyse's first round on record, in Jun 2019, was backed by LSP, Epimède and Société Fédérale de Participations et d’Investissement and 1 others.

### What stage is Imcyse at?

Imcyse's latest named round is a Series B, in Feb 2021.

### Where is Imcyse based?

Imcyse is based in Belgium.

## Companies like Imcyse

In the same sector, and raised in the last eighteen months.

[**Novadip Biosciences** $43M · Sept 2026](https://millionrounds.com/company/novadip-biosciences)[**Amyl Therapeutics** $9.6M · Sept 2026](https://millionrounds.com/company/amyl-therapeutics)[**Revier Therapeutics** $7.0M · Aug 2026](https://millionrounds.com/company/revier-therapeutics)[**Sightera Biosciences** $3.4M · Jul 2026](https://millionrounds.com/company/sightera-biosciences)[**Rainbow Crops** $18M · Jun 2026](https://millionrounds.com/company/rainbow-crops)[**ReVision Implant** $4.7M · May 2026](https://millionrounds.com/company/revision-implant)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app